Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000921895-25-003160·BIOTECHNOLOGY VALUE FUND L P
Schedule 13D ownership disclosure
INVENTIVA SA
Ordinary Shares, nominal value (euro)0.01 per share · CUSIP: 46124U107
Event date: 2025-11-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L PReported CIK 0000918923
Shares: 5,654,825.00 · Class: 2.9%
- BVF I GP LLCReported CIK 0001803805
Shares: 5,654,825.00 · Class: 2.9%
- BIOTECHNOLOGY VALUE FUND II LPReported CIK 0001102444
Shares: 3,321,861.00 · Class: 1.7%
- BVF II GP LLCReported CIK 0001803806
Shares: 3,321,861.00 · Class: 1.7%
- Biotechnology Value Trading Fund OS LPReported CIK 0001660683
Shares: 397,086.00 · Class: 0.2%
- BVF Partners OS Ltd.Reported CIK 0001660684
Shares: 397,086.00 · Class: 0.2%
- BVF GP HOLDINGS LLCReported CIK 0001803809
Shares: 8,976,686.00 · Class: 4.7%
- BVF PARTNERS L P/ILReported CIK 0001055947
Shares: 9,569,863.00 · Class: 4.99%
- BVF INC/ILReported CIK 0001056807
Shares: 9,569,863.00 · Class: 4.99%
- LAMPERT MARK NReported CIK 0001233840
Shares: 9,569,863.00 · Class: 4.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-25-003160
- Form type
- SCHEDULE 13D/A
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Nov 19, 2025
- Reporting period
- Nov 17, 2025
- Description
- Schedule 13D beneficial ownership